Overview

Fasturtec TLS Treatment / Prophylysis

Status:
Completed
Trial end date:
2004-07-01
Target enrollment:
Participant gender:
Summary
An open-label study to determine the efficacy and safety of Rasburicase used for the prevention and treatment of tumor lysis syndrome
Phase:
Phase 4
Details
Lead Sponsor:
Sanofi
Treatments:
Rasburicase